BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11820033)

  • 1. [Clinical case of the month. Natural history of morbid obesity: towards insulin-requiring type 2 diabetes and reversal after bariatric surgery].
    De Flines J; Letiexhe MR; Desaive C; Scheen AJ
    Rev Med Liege; 2001 Dec; 56(12):816-22. PubMed ID: 11820033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
    Gumbs AA; Modlin IM; Ballantyne GH
    Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity surgery: evidence for diabetes prevention/management.
    Cummings S; Apovian CM; Khaodhiar L
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S40-4. PubMed ID: 18358255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bariatric surgery in a patient with adipositas permagna and uncontrolled insulin resistance].
    Haak T; Horbach T
    Dtsch Med Wochenschr; 2012 May; 137(19):993-6. PubMed ID: 22549255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
    Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS
    Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass.
    Cotillard A; Poitou C; Torcivia A; Bouillot JL; Dietrich A; Klöting N; Grégoire C; Lolmede K; Blüher M; Clément K
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1466-70. PubMed ID: 24780048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
    Nannipieri M; Mari A; Anselmino M; Baldi S; Barsotti E; Guarino D; Camastra S; Bellini R; Berta RD; Ferrannini E
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1372-9. PubMed ID: 21778221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?
    Andreelli F; Amouyal C; Magnan C; Mithieux G
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):499-507. PubMed ID: 20152734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
    Mingrone G
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary treatment of a patient with type 2 diabetes and morbid obesity, or perhaps already a surgical diabetology.
    Szcześniak G; Jaworska J; Jaworski T; Dziemidok P
    Ann Agric Environ Med; 2012; 19(4):798-801. PubMed ID: 23311810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus.
    Monte SV; Caruana JA; Ghanim H; Sia CL; Korzeniewski K; Schentag JJ; Dandona P
    Surgery; 2012 Apr; 151(4):587-93. PubMed ID: 22088821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic surgery: an increasing place in the management of diabetes].
    De Flines J; Franck M; Rorive M; De Roover A; Paquot N; Scheen AJ
    Rev Med Suisse; 2012 Aug; 8(351):1621-4, 1626-7. PubMed ID: 22988716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanisms of surgical treatment of type 2 diabetes.
    Mason EE
    Obes Surg; 2005 Apr; 15(4):459-61. PubMed ID: 15946422
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastric bypass surgery for severe obesity: what can be achieved?
    He M; Stubbs R
    N Z Med J; 2004 Dec; 117(1207):U1207. PubMed ID: 15608802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic effects of bariatric surgery].
    Winkler G
    Orv Hetil; 2013 Jan; 154(1):3-9. PubMed ID: 23274228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Our experiences with laparoscopic Roux-en-Y gastric bypass (LRYGB) and description of the surgical technique].
    Mohos E; Nagy A; Schmaldienst E; Prager M
    Magy Seb; 2011 Feb; 64(1):12-7. PubMed ID: 21330258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success?
    Frezza EE
    Obes Surg; 2004 Aug; 14(7):999-1005. PubMed ID: 15329192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gastric bypass versus diet on cardiovascular risk factors.
    Raffaelli M; Guidone C; Callari C; Iaconelli A; Bellantone R; Mingrone G
    Ann Surg; 2014 Apr; 259(4):694-9. PubMed ID: 23979288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year outcome after gastric bypass for morbid obesity in a Norwegian cohort.
    Aftab H; Risstad H; Søvik TT; Bernklev T; Hewitt S; Kristinsson JA; Mala T
    Surg Obes Relat Dis; 2014; 10(1):71-8. PubMed ID: 24182445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.